{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:02:59Z","timestamp":1761102179821},"reference-count":22,"publisher":"American Chemical Society (ACS)","issue":"4","license":[{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Prince Sultan Military Medical City - Saudi Arabia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Am. Soc. Mass Spectrom."],"published-print":{"date-parts":[[2016,4,1]]},"DOI":"10.1007\/s13361-015-1318-4","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T18:31:09Z","timestamp":1453401069000},"page":"719-725","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients"],"prefix":"10.1021","volume":"27","author":[{"given":"Fahad J.","family":"Alharbi","sequence":"first","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, Birmingham, England"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarekegn","family":"Geberhiwot","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Medical Centre, University Hospitals Birmingham NHS Foundation Trust, B15 2TH, Birmingham, England"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derralynn A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Haematology, Lysosomal Storage Disorders Unit, Royal Free Hospital, NW3 2QG, London, England"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas G.","family":"Ward","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, Birmingham, England"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"key":"CR1\/citCR1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-30"},{"key":"CR2\/citCR2","unstructured":"Desnick, R.J., Allen, K.Y., Desnick, S.J., Raman, M.K., Bernlohr, R.W., Krivit, W.: Fabry\u2019s disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J. Lab. Clin. Med.81(2),157\u201371 (1973)"},{"key":"CR3\/citCR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196705252762101"},{"key":"CR4\/citCR4","doi-asserted-by":"publisher","DOI":"10.1086\/504601"},{"key":"CR5\/citCR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.01.003"},{"key":"CR6\/citCR6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.249"},{"key":"CR7\/citCR7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01478472"},{"key":"CR8\/citCR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"CR9\/citCR9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"CR10\/citCR10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi152"},{"key":"CR11\/citCR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0484-8"},{"key":"CR12\/citCR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-4415-x"},{"key":"CR13\/citCR13","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.041418"},{"key":"CR14\/citCR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2007.10.001"},{"key":"CR15\/citCR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/CCLM.2010.048","volume":"48","author":"Kr\u00fcger R","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"CR16\/citCR16","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.728"},{"key":"CR17\/citCR17","doi-asserted-by":"publisher","DOI":"10.1021\/ac203433e"},{"key":"CR18\/citCR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2004.02.032"},{"key":"CR19\/citCR19","doi-asserted-by":"publisher","DOI":"10.2174\/092986712800784739"},{"key":"CR20\/citCR20","doi-asserted-by":"publisher","DOI":"10.1021\/ac401542k"},{"key":"CR21\/citCR21","doi-asserted-by":"publisher","DOI":"10.1007\/s13361-014-1060-3"},{"key":"CR22\/citCR22","unstructured":"Martincova, O., Chrastina, P., Berna, L., Soucek, R., Ledvinova, J.: Tandem mass spectrometry of globotriaosylceramide in human plasma and urine for diagnosis and therapy monitoring in fabry disease. In journal of inherited metabolic disease. Spring. Van Godew.30,3311Gz Dord., Nether. 162\u2013162 (2005)"}],"container-title":["Journal of the American Society for Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13361-015-1318-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13361-015-1318-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1007\/s13361-015-1318-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T15:31:55Z","timestamp":1692199915000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1007\/s13361-015-1318-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4,1]]}},"alternative-id":["10.1007\/s13361-015-1318-4"],"URL":"https:\/\/doi.org\/10.1007\/s13361-015-1318-4","relation":{},"ISSN":["1044-0305"],"issn-type":[{"value":"1044-0305","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}